1. Home
  2. HALO vs BYD Comparison

HALO vs BYD Comparison

Compare HALO & BYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • BYD
  • Stock Information
  • Founded
  • HALO 1998
  • BYD 1973
  • Country
  • HALO United States
  • BYD United States
  • Employees
  • HALO N/A
  • BYD N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • BYD Hotels/Resorts
  • Sector
  • HALO Health Care
  • BYD Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • BYD Nasdaq
  • Market Cap
  • HALO 7.4B
  • BYD 6.1B
  • IPO Year
  • HALO N/A
  • BYD 1993
  • Fundamental
  • Price
  • HALO $52.80
  • BYD $81.57
  • Analyst Decision
  • HALO Buy
  • BYD Buy
  • Analyst Count
  • HALO 9
  • BYD 14
  • Target Price
  • HALO $63.56
  • BYD $80.08
  • AVG Volume (30 Days)
  • HALO 2.9M
  • BYD 963.5K
  • Earning Date
  • HALO 08-05-2025
  • BYD 07-24-2025
  • Dividend Yield
  • HALO N/A
  • BYD 0.88%
  • EPS Growth
  • HALO 55.40
  • BYD 9.82
  • EPS
  • HALO 3.76
  • BYD 6.13
  • Revenue
  • HALO $1,084,306,000.00
  • BYD $3,961,238,000.00
  • Revenue This Year
  • HALO $25.77
  • BYD $1.65
  • Revenue Next Year
  • HALO $18.01
  • BYD $2.15
  • P/E Ratio
  • HALO $14.37
  • BYD $13.32
  • Revenue Growth
  • HALO 25.64
  • BYD 6.06
  • 52 Week Low
  • HALO $42.01
  • BYD $52.76
  • 52 Week High
  • HALO $70.51
  • BYD $82.21
  • Technical
  • Relative Strength Index (RSI)
  • HALO 50.36
  • BYD 73.65
  • Support Level
  • HALO $51.06
  • BYD $77.19
  • Resistance Level
  • HALO $54.25
  • BYD $79.04
  • Average True Range (ATR)
  • HALO 1.22
  • BYD 1.50
  • MACD
  • HALO 0.23
  • BYD 0.43
  • Stochastic Oscillator
  • HALO 84.97
  • BYD 93.05

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About BYD Boyd Gaming Corporation

Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.

Share on Social Networks: